Takeda Pharmaceutical TAK
NYSE TAK
$18.35 -0.16 (-0.86%)
As of: Sep 30, 2026 · 10:18 AM EDT

Takeda Pharmaceutical (TAK) Assets (2017 - 2026)

Updated

Takeda Pharmaceutical (TAK) reported Assets of $98.27 billion for the quarter ended Jun 30, 2026, up 1.5% from $96.79 billion a year earlier but down 0.6% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Assets (2017 - 2026) Analysis & Trends

As of Mar 31, 2026, Takeda Pharmaceutical posted Assets of $103.05 billion, up 10.2% from the prior year.

  • Assets has a five-year compound annual growth rate of -3.3% (years ended Mar 2021 to Mar 2026).
  • By year, Assets came in at $93.54 billion in the year ended Mar 31, 2025 (-10.7%), $104.77 billion in the year ended Mar 31, 2024 (+1.4%), $103.32 billion in the year ended Mar 31, 2023 (-12.0%) and $117.38 billion in the year ended Mar 31, 2022 (-3.6%).
  • Five-year quarterly Assets spans a low of $93.39 billion in the quarter ended Mar 31, 2025 and a high of $113.39 billion in the quarter ended Mar 31, 2022.
  • Year over year, Assets has now increased in each of the last four quarters, with an average decline of 1.1% over the last eight quarters.
  • The high point for year-over-year Assets in five years was the quarter ended Mar 31, 2026 (growth of 5.9%); the low point was the quarter ended Mar 31, 2025 (a decline of 8.4%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $98.91 billion (quarter ended Mar 31, 2026), $100.12 billion (quarter ended Dec 31, 2025) and $98.21 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Takeda Pharmaceutical 2.74 Bn -23.77 Bn 5.10 Bn 98.27 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 98.27 Bn
Mar 31, 2026 98.91 Bn
Dec 31, 2025 100.12 Bn
Sep 30, 2025 98.21 Bn
Jun 30, 2025 96.79 Bn
Mar 31, 2025 93.39 Bn
Dec 31, 2024 99.37 Bn
Sep 30, 2024 97.70 Bn
Jun 30, 2024 104.25 Bn
Mar 31, 2024 101.95 Bn
Dec 31, 2023 96.22 Bn
Sep 30, 2023 102.98 Bn
Jun 30, 2023 107.94 Bn
Mar 31, 2023 105.52 Bn
Dec 31, 2022 95.59 Bn
Sep 30, 2022 105.63 Bn
Jun 30, 2022 108.76 Bn
Mar 31, 2022 113.39 Bn
Jun 30, 2021 115.62 Bn
Mar 31, 2021 121.99 Bn
API Access

Takeda Pharmaceutical Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=TAK&period=max&api_key=YOUR_API_KEY